B. Spellberg and D. Gilbert, The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett, Clinical Infectious Diseases, vol.288, issue.5464, pp.71-75, 2014.
DOI : 10.1126/science.288.5464.287

D. Livermore, S. Mushtaq, M. Warner, J. Zhang, S. Maharjan et al., Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates, Journal of Antimicrobial Chemotherapy, vol.370, issue.1, pp.48-53, 2011.
DOI : 10.1016/j.bbrc.2008.03.045

I. Galani, M. Souli, G. Daikos, Z. Chrysouli, G. Poulakou et al., spp. from Athens, Greece, Journal of Chemotherapy, vol.15, issue.46, pp.191-194, 2012.
DOI : 10.1111/j.1469-0691.2011.03738.x

M. Scher, S. Ludington-hoe, F. Kaffashi, D. Holditch-davis, and K. Loparo, Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors, Sci Transl Med, vol.120, pp.1812-1818, 2010.

M. El-nakeeb, H. Abou-shleib, A. Khalil, H. Omar, and O. El-halfawy, In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates, Brazilian Journal of Microbiology, vol.42, issue.3, pp.980-991, 2011.
DOI : 10.1590/S1517-83822011000300018

S. Dastidar, A. Chaudhury, S. Annadurai, S. Roy, M. Mookerjee et al., Antimicrobial Action of Fluphenazine, Journal of Chemotherapy, vol.23, issue.3, pp.201-206, 1995.
DOI : 10.1111/j.1699-0463.1993.tb00133.x

J. Molnar, Y. Mandi, and J. Kiraly, Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine, Acta Microbiologica Academiae Scientiarum Hungaricae, vol.23, pp.45-54, 1976.

H. Thanacoody and . Thioridazine, Thioridazine: resurrection as an antimicrobial agent?, British Journal of Clinical Pharmacology, vol.9, issue.5, pp.566-574, 2007.
DOI : 10.1093/jac/dkm071

R. Mazumder, K. Ganguly, S. Dastidar, and A. Chakrabarty, Trifluoperazine: a broad spectrum bactericide especially active on staphylococci and vibrios, International Journal of Antimicrobial Agents, vol.18, issue.4, pp.403-406, 2001.
DOI : 10.1016/S0924-8579(01)00324-7

S. Dastidar, S. Debnath, K. Mazumdar, K. Ganguly, and A. Chakrabarty, Triflupromazine: a microbicide non-antibiotic compound, Acta Microbiologica et Immunologica Hungarica, vol.51, issue.1-2, pp.75-83, 2004.
DOI : 10.1556/AMicr.51.2004.1-2.5

S. Annadurai, S. Basu, S. Ray, S. Dastidar, and A. Chakrabarty, Antibacterial activity of the antiinflammatory agent diclofenac sodium, Indian J Exp Biol, vol.36, pp.86-90, 1998.

N. Dutta, K. Mazumdar, S. Dastidar, A. Chakrabarty, Y. Shirataki et al., In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA, In Vivo, vol.19, pp.539-546, 2005.

H. Kruszewska, T. Zareba, and S. Tyski, Search of antimicrobial activity of selected non-antibiotic drugs, Acta Poloniae Pharmaceutica, vol.59, pp.436-445, 2002.

S. Dastidar, J. Kristiansen, J. Molnar, and L. Amaral, Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria, Antibiotics, vol.43, issue.1, pp.58-72, 2013.
DOI : 10.1016/S0924-8579(03)00207-3

R. Köck, P. Werner, A. Friedrich, C. Fegeler, and K. Becker, Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population, New Microbes and New Infections, vol.9, pp.24-34, 2015.
DOI : 10.1016/j.nmni.2015.11.004

C. Woolverton, J. Fulton, S. Salstrom, J. Hayslip, N. Haller et al., Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibiotic, Journal of Antimicrobial Chemotherapy, vol.48, issue.6, pp.861-867, 2001.
DOI : 10.1093/jac/48.6.861
URL : https://academic.oup.com/jac/article-pdf/48/6/861/9842987/480861.pdf

M. Zilberman and J. Elsner, Antibiotic-eluting medical devices for various applications, Journal of Controlled Release, vol.130, issue.3, pp.202-215, 2008.
DOI : 10.1016/j.jconrel.2008.05.020

H. Bunjes, Lipid nanoparticles for the delivery of poorly water-soluble drugs, Journal of Pharmacy and Pharmacology, vol.51, issue.11, pp.1637-1645, 2010.
DOI : 10.1016/j.phrs.2004.10.007
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.2010.01024.x/pdf

A. Umerska, C. Mouzouvi, A. Bigot, and P. Saulnier, Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers, International Journal of Pharmaceutics, vol.493, issue.1-2, pp.224-232, 2015.
DOI : 10.1016/j.ijpharm.2015.07.008
URL : https://hal.archives-ouvertes.fr/hal-01392459

I. Salem, D. Flasher, and N. Düzgüne?, Liposome-Encapsulated Antibiotics1, Liposomes, pp.261-291, 2005.

A. Hidalgo, W. Caetano, M. Tabak, and O. Oliveira, Interaction of two phenothiazine derivatives with phospholipid monolayers, Biophysical Chemistry, vol.109, issue.1, pp.85-104, 2004.
DOI : 10.1016/j.bpc.2003.10.020

B. Heurtault, P. Saulnier, B. Pech, J. Proust, and J. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002.
DOI : 10.1023/A:1016121319668

N. Huynh, C. Passirani, P. Saulnier, and J. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

C. Mouzouvi, A. Umerska, A. Bigot, and P. Saulnier, Surface active properties of lipid nanocapsules, PLOS ONE, vol.26, issue.8, pp.179211-28796777, 2017.
DOI : 10.1371/journal.pone.0179211.t004
URL : http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179211&type=printable

A. Umerska, V. Cassisa, G. Bastiat, H. Nehme, F. Manero et al., Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against <em>Staphylococcus aureus</em>, International Journal of Nanomedicine, vol.12, pp.5687-5699, 2017.
DOI : 10.2147/IJN.S139625
URL : https://www.dovepress.com/getfile.php?fileID=37857

A. Umerska, V. Cassisa, N. Matougui, M. Joly-guillou, M. Eveillard et al., Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants, European Journal of Pharmaceutics and Biopharmaceutics, vol.108, pp.100-110, 2016.
DOI : 10.1016/j.ejpb.2016.09.001
URL : https://hal.archives-ouvertes.fr/hal-01413267

A. Umerska, N. Matougui, A. Groo, and P. Saulnier, Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules, International Journal of Pharmaceutics, vol.506, issue.1-2, pp.191-200, 2016.
DOI : 10.1016/j.ijpharm.2016.04.028
URL : https://hal.archives-ouvertes.fr/hal-01392465

C. Valcourt, P. Saulnier, A. Umerska, M. Zanelli, A. Montagu et al., Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria, International Journal of Pharmaceutics, vol.498, issue.1-2, pp.23-31, 2016.
DOI : 10.1016/j.ijpharm.2015.11.042
URL : https://hal.archives-ouvertes.fr/hal-01388818

A. Umerska, K. Paluch, M. Santos-martinez, C. Medina, O. Corrigan et al., Chondroitin-based nanoplexes as peptide delivery systems ??? Investigations into the self-assembly process, solid-state and extended release characteristics, European Journal of Pharmaceutics and Biopharmaceutics, vol.93, pp.242-253, 2015.
DOI : 10.1016/j.ejpb.2015.04.006
URL : https://bradscholars.brad.ac.uk/bitstream/10454/9416/1/Paluch_EJPB.pdf

A. Delcour, Outer membrane permeability and antibiotic resistance, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1794, issue.5, pp.808-816, 2009.
DOI : 10.1016/j.bbapap.2008.11.005
URL : http://europepmc.org/articles/pmc2696358?pdf=render

H. Nikaido, Molecular Basis of Bacterial Outer Membrane Permeability Revisited, Microbiology and Molecular Biology Reviews, vol.67, issue.4, pp.593-656, 2003.
DOI : 10.1128/MMBR.67.4.593-656.2003
URL : http://mmbr.asm.org/content/67/4/593.full.pdf

P. Muhlardt, J. Menzel, J. Golecki, and V. Speth, Outer Membrane of Salmonella. Sites of Export of Newly Synthesised Lipopolysaccharide on the Bacterial Surface, European Journal of Biochemistry, vol.69, issue.3, pp.471-481, 1973.
DOI : 10.1016/0006-3002(61)90044-0

P. Plésiat and H. Nikaido, Outer membranes of Gram-negative bacteria are permeable to steroid probes, Molecular Microbiology, vol.55, issue.10, pp.1323-1333, 1992.
DOI : 10.1021/j150474a012

H. Zgurskaya, Multicomponent drug efflux complexes: architecture and mechanism of assembly, Future Microbiology, vol.380, issue.7, pp.919-932, 2009.
DOI : 10.1016/j.bbrc.2009.01.081
URL : http://europepmc.org/articles/pmc2763196?pdf=render

H. Nikaido, Multidrug efflux pumps of gram-negative bacteria., Journal of Bacteriology, vol.178, issue.20, pp.5853-5859, 1996.
DOI : 10.1128/jb.178.20.5853-5859.1996
URL : http://jb.asm.org/content/178/20/5853.full.pdf

A. Dasgupta, S. Dastidar, Y. Shirataki, and N. Motohashi, Antibacterial Activity of Artificial Phenothiazines and Isoflavones from Plants, Top Heterocycl Chem, vol.15, pp.67-132, 2008.
DOI : 10.1007/7081_2007_108

A. Umerska, K. Paluch, M. Santos-martinez, O. Corrigan, C. Medina et al., Self-Assembled Hyaluronate/Protamine Polyelectrolyte Nanoplexes: Synthesis, Stability, Biocompatibility and Potential Use as Peptide Carriers, Journal of Biomedical Nanotechnology, vol.10, issue.12, pp.3658-3673, 2014.
DOI : 10.1166/jbn.2014.1878

L. Boge, H. Bysell, L. Ringstad, D. Wennman, A. Umerska et al., Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect, Langmuir, vol.32, issue.17, pp.4217-4228, 2016.
DOI : 10.1021/acs.langmuir.6b00338
URL : https://hal.archives-ouvertes.fr/hal-01392483

L. Boge, A. Umerska, N. Matougui, H. Bysell, L. Ringstad et al., Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability, International Journal of Pharmaceutics, vol.526, issue.1-2, pp.400-412, 2017.
DOI : 10.1016/j.ijpharm.2017.04.082